Bioadhesive polymers can serve as surgical sealants with a wide range of potential clinical applications, including augmentation of wound closure and acute induction of hemostasis. Key determinants of sealant efficacy include the strength and duration of tissue-material adhesion, as well as material biocompatibility. Canonical bioadhesive materials, however, are limited by a tradeoff among performance criteria that is largely governed by the efficiency of tissue-material interactions. In general, increasingly bioreactive materials are endowed with greater bioadhesive potential and protracted residence time, but incite more tissue damage and localized inflammation. One emergent strategy to improve sealant clinical performance is application-specific material design, with the goal of leveraging both local soft tissue surface chemistry and environmental factors to promote adhesive tissue-material interactions. We hypothesize that co-polymer systems with equivalent bioreactive group densities (isoreactive) but different amounts/oxidation states of constituent polymers will exhibit differential interactions across soft tissue types. We synthesized an isoreactive family of aldehyde-mediated co-polymers, and subjected these materials to physical (gelation time), mechanical (bulk modulus and adhesion strength), and biological (in-vitro cytotoxicity and in-vivo biocompatibility) assays indicative of sealant performance. Results show that while bioadhesion to a range of soft tissue surfaces (porcine aortic adventitia, renal artery adventitia, renal cortex, and pericardium) varies with isoreactive manipulation, general indicators of material biocompatibility remain constant. Together these findings suggest that isoreactive tuning of polymeric systems is a promising strategy to circumvent current challenges in surgical sealant applications.
Introduction
Bioadhesive polymeric materials have an established history of medical use, with utilities ranging from acute induction of hemostasis in cases of trauma to augmentation of wound closure in surgical applications. [1] [2] [3] Irrespective of specific use, the safety and efficacy of these materials largely depend on sufficient adherence to soft tissue surfaces, adequate residence time at the site of application, and acceptable biocompatibility. [4] Clearly, the required bioadhesive strength, material degradation/erosion kinetics, and tolerable immune/inflammatory response will all vary by application, with internal application sites subjected to high mechanical loads presenting the greatest challenge.
Bioadhesive materials can be loosely divided into two categories which exemplify the current state of sealant technologies. On the one hand, there are numerous synthetic materials which adhere vigorously to the full range of soft tissues and persist at the site of application for long periods of time. Many of these materials are based on cyanoacrylate and its derivatives, wherein adhesive bonds with soft tissues are rapidly formed in the presence of trace water. [5] [6] [7] [8] [9] Although endowed with high bioadhesive potential, these materials and their degradation by-products induce significant inflammation, confer destructive compressive mechanical forces to underlying soft tissue, and are therefore mainly used in dermal applications. Conversely, polymers based on natural compounds, most notably fibrin, are biocompatible in the context of internal applications. [10] [11] [12] However, the bioadhesion strength of these formulations is minimal, and material degradation/erosion processes are accelerated by enzymatic activity. While cyanoacrylate-and fibrin-based materials are only a small fraction of proposed technologies, their inherent limitations/tradeoffs persist to various degrees across all materials considered for soft tissue sealant applications (Table 1 ) [13] [14] .
To address the long-standing challenges limiting sealant use and efficacy, recent efforts have focused on tissue-specific material design. [15] [16] These studies have demonstrated that polymer-based adhesive bond formation with various soft tissues is concurrently modulated by the mode of chemical bond formation and the targeted tissue surface characteristics. Moreover, the sensitivity of polymer adhesion strength to increasingly bioreactive material formulations varies with target tissue type, suggesting that in addition to careful selection of bioreactive group chemistry, optimization of bioreactive group content available for adhesive bond formation must be done on a tissue-specific basis. Building upon this theme, recent studies have shown that polymer-based adhesion can significantly vary in the context of certain disease states, providing further impetus for application-specific material design. [17] [18] Clearly, the notion of de- 
Synthesis of Dextran Aldehyde-Chitosan Amine Co-Polymer
Dextran oxidation The synthesis of dextran aldehyde has been previously described. [19] Briefly, a 10 wt.% dextran solution (average molecular weight of 
Bulk Material Properties
Gelation time The gelation time of each co-polymer formulation is defined as the time required for solid globule formation following a 100 μL injection onto a glass surface maintained at 37˚C. The injected material was continuously agitated with a magnetic stirring rod, and solid globule formation was visually determined.
Compressive modulus Cylindrical test samples (diameter = 9.5 mm and height = 6.25 mm) were prepared via co-polymer injection into a silicon mold.
Samples were allowed five minutes to cross-link, after which they were carefully removed from the mold. A uniaxial mechanical testing system (Bose® Biodynamic Test Instrument, Minnetonka, MN) configured for unconfined compression testing was used to apply a ramped displacement (5 mm total displacement; displacement rate of 0.005 mm/sec) to each sample. Force and displacement data were continuously recorded (data acquisition rate of 20 points/sec) using an integrated system software (Wintest®, Minnetonka, MN). The mechanical behavior of these materials was assumed to be linear, elastic, homogeneous, and isotropic, and the materials were modeled as incompressible solids due to the high water content. In the context of these assumptions, recorded mechanical data were processed to yield true stress versus strain curves and ultimately calculate the compressive elastic modulus (E) of each test sample (i.e. slope of the stress-strain curve).
Adhesive Material Properties
The Adhesion strength Co-polymer adhesive mechanics were quantified using a previously described testing methodology. [19] [21] Briefly, tissue-material-tissue constructs were formed using two cylindrical biopsy specimens (8 mm diameter and 1 mm thickness) of a given tissue type, between which co-polymer (100 μL) was injected. Constructs were carefully mounted within a mechanical testing system (Bose® Biodynamic Test Instrument, Minnetonka, MN) configured for uniaxial tensile testing. A compressive setting force (1 N) was applied to the constructs for a five minute period, followed by application of a ramped tensile displacement (0.05 mm/s) until the occurrence of failure. Integrated system software (Wintest) continuously acquired load and displacement data, which were later processed to yield the ultimate true stress of the construct. The ultimate stress serves as an indicator of the adhesive strength of the co-polymer to the targeted soft tissue surface.
Material Biocompatibility
The biocompatibility of isoreactive co-polymer formulations (A-D) was assessed via in-vitro cytotoxicity studies and in-vivo sub-cutaneous implantation studies.
While neither method is directly relevant to specific sealant applications, these studies provide general indications as to whether isoreactive design manipulations within the co-polymer system will likely impact material biocompatibility.
In-vitro cytotoxicity Primary rat fibroblasts (~7e4 cells/mL) were seeded on to 24 well plates and cultured to confluence using standard media (Cell Applications, Inc.). Each well plate was then drained of media to facilitate direct injection of co-polymers (100 μL) onto the cell monolayer. Materials were allowed five minutes for cross-linking, after which fresh culture media was replenished within each well plate. Following a 48 hour incubation period, a neutral red uptake (NRU) assay (Sigma Aldrich) for cell viability/cytotoxicity was performed.
The assay consist of a two hour co-incubation of cells/materials with the supravital dye (neutral red), a washing treatment, and subsequent quantification of absorbance. Obtained absorbance measurements were normalized with respect to control wells (identical cell cultures with no material exposure) and reported for each co-polymer formulation (A-D).
In-vivo studies Sterile sample preparations of co-polymer formulations A-D were prepared for subcutaneous implantation in adult male Sprague Dawley rats (180 -220 g, Charles River Labs). A randomized pattern of five discrete subcutaneous dorsal implantation sites was assigned to each rat (n = 12). Each of four implantation sites was assigned one co-polymer formulation (A-D), wherein a 100 μL injection was sterilely delivered. The fifth implantation site was used for a sham procedure (100 μL saline injection). After 7 days, the rats were sacrificed and tissue was harvested for histological and molecular assays. 
Statistical Analysis
Obtained data were analyzed using Mann-Whitney tests for significance between groups and Wilcoxon rank tests for pair-wise comparisons within groups, with groups defined by co-polymer formulation (experimental groups) or included as controls (sham procedure for in-vivo studies). Differences were considered to be significant if p-value < 0.05.
Results and Discussion

Co-Polymer Bioreactive Group Content and Linear Distribution Parameter
Isoreactive material synthesis yielded four dextran aldehyde-chitosan co-polymer formulations (A-D) that facilitate investigation of the proposed material design strategy (Table 2) . Specifically, the dextran aldehyde components of these formulations were endowed with equivalent total aldehyde content (2.3 × 10 20 groups/mL), but differed in terms of oxidation states/solid content. In all formulations, the chitosan component was identical, and provided an amine group density of 7.6 × 10 19 groups/mL. Therefore, in all co-polymer formulations, the ratio of aldehyde: amine groups were 3:1. The relative concentrations of these groups ensure that aldehydes are available for both cohesive bond formation within the co-polymer network and adhesive bond formation with tissue-present amines. The selection of a 3:1 reactive group ratio was motivated by previous findings with an analogous material system that show a notable decline in biocompatibility with increasing free aldehyde content [19] .
Bulk Property Response to Isoreactive Design Manipulations
Assays were conducted to determine if key intrinsic properties for surgical sealant applications vary in response to isoreactive manipulation. Specifically, the impact on co-polymer gelation kinetics (mean time for liquid-solid phase transition under controlled component mixing conditions) and the compressive elastic modulus (determined via unconfined uniaxial compression testing of cylindrical material samples) were determined. Among the examined co-polymer formulations, no significant differences were found in either mean gelation times or compressive moduli (Figure 2 ). These findings suggest that for these base material constituents (40 kDa dextran and 340 kDa chitosan) prepared within experimental range of dextran oxidations and solid contents, molecular mobility and steric effects within the forming co-polymer networks were similar, leading to similar rates and degrees of cross-linking. Table 2 . Co-polymer formulations. Four variants of dextran aldehyde (A-D) with titrated percent oxidation and solid contents were synthesized for this study. The solid content of each dextran aldehyde polymer within the delivery solution was tuned such that all formulations contained an equivalent aldehyde group density prior to mixing with a 2% chitosan solution. The aldehyde: amine ratio within the resultant cross-linked co-polymer systems was therefore equivalent (3:1) in all formulations. 
Tissue-Specific Adhesion Response to Isoreactive Design Manipulations
The adhesive interactions between co-polymer formulations and a range of soft tissue surfaces were assessed in terms of tissue-material interfacial continuity and maximal adhesion strength. The soft tissue surfaces considered were the aortic adventitia, renal artery adventitia, renal cortex, and pericardium, all of which are potential targets for clinical sealant applications (Figure 3(a) ). Significant differences in adhesion, manifested by both interfacial continuity and maximum adhesion stress prior to interfacial failure, were found among co-polymer formulations when applied to each tissue type. For example, interfacial continuity with the aortic adventitia exhibited a nonmonotonic dependence on dextran percent oxidation/solid content, and was maximal with application of formulation A (lowest percent oxidation). Conversely, interfacial continuity on renal cortex applications was insensitive to explored isoreactive manipulation (Figure 3(b) ).
Similar tissue-specific responses were found when adhesion was assessed from a mechanical perspective (Figure 3(c) ). Interestingly, among the co-polymer formulations tested, the maximal adhesion strength to each tissue type occurred when the dextran percent oxidation was either its lowest (formulation A, aortic adventitia and pericardium) or highest (formulation D, renal artery adventitia and renal cortex) value. This finding suggests that with respect to the defined mode of isoreactive variation, the optimal value for bioadhesion to each of these tissue types falls outside of the range covered by our experimental material system. Moreover, direct correlation (R = 0.86, p-value < 0.005) between tissuematerial interfacial fluorescence and maximal adhesion strength supports the interchangeability of these response variable for assessment of tissue-material adhesion (Figure 3(d) ). 
Cell and Tissue Response to Isoreactive Design Manipulations
Assays to determine the cytotoxic effects of formulations A-D demonstrated that co-polymer formulations are similarly tolerated by the cell culture monolayer. All formulations maintained greater than 58% viability of the control wells, with no significant differences in cytotoxicity among the material formulations ( Figure 4) . Moreover, no trend in cytotoxicity with respect to titrated polymer design variables (oxidation state and solid content) emerged among the formulations tested, suggesting that isoreactive manipulations have no discernable impact on this aspect of material biocompatibility.
While cytotoxicity assays suggest reasonable and consistent material biocompatibility, complementary subcutaneous implantation studies were undertaken to quantify and compare the in-vivo tissue response to isoreactive co-polymers.
Obtained results demonstrate no significant elevations in inflammatory cell count relative to sham, and no dependence on dextran oxidation state/solid content was observed among the formulations tested ( Figure 5 ). Tissue samples extracted from each implant site were subjected to a molecular cytokine assay, in which cytokine markers of inflammation were quantified with a rat-specific multiplex array. Relative to the sham procedure, no significant differences in cytokine concentrations were found with co-polymer implantation, and once again no trend in cytokine expression with respect to isoreactive manipulation ( Figure 6 ). Taken together, these findings demonstrate the general biocompatibility dextran-chitosan co-polymers, and more importantly support the hypothesized insensitivity of biocompatibility to isoreactive design manipulation.
Study Limitations
There are several study limitations that should be considered upon interpretation of our findings. First, we have not directly shown that the surface-present biochemical groups (amine groups) targeted for adhesive bond formation in fact have different densities/spatial distributions among tissue surfaces. While beyond the scope of the present study, the tissue-present amine group distribution could be quantified with the use of functional atomic force microscopy (fAFM). [16] [22] Indeed, future studies using fAFM on soft tissue and material surfaces for the purpose of quantifying and comparing the spacing/density of the Figure 4 . In-vitro cell response. The cytotoxicity of co-polymer formulations was quantified via neutral red uptake (NRU) assay formulations following direct material application to fibroblast cultures. There were no significant differences or discernable trends with respect dextran aldehyde percent oxidation/solid content. Figure 6 . Cytokine activity. Select interleukin (IL) concentrations (IL-1β, IL-2, and IL-6) in local tissue were quantified 7 days after subcutaneous dorsal implantation of co-polymers in rats. No significant elevations occured with respect to sham, and there were no significant differences or discernable trends with respect to dextran aldehyde percent oxidation/solid content.
relevant (reciprocal) reactive groups would provide a means to directly test the proposed approach to enhance bioadhesion. Second, while bioadhesion strength and interfacial morphology were assessed in a tissue-specific manner, we only provide general measures of material biocompatibility (in-vitro cytotoxicity and in-vivo tissue response following subcutaneous implantation). Moreover, the time point of the in-vivo studies (7 days post implantation) may have failed to detect the peak of the inflammatory response, which would likely occur upon material erosion and by-product generation. More comprehensive evaluation of the proposed design strategy, specifically the insensitivity of biocompatibility to isoreactive design manipulation, requires assessment of local tissue response in various implant scenarios and over the complete residence time of the material.
Conclusion
The aim of this study was to evaluate a novel approach for tissue-specific design of surgical sealants. Specifically, we investigated the potential for isoreactive tuning of polymer design variables to enhance tissue-material adhesion without compromising biocompatibility. Using an experimental aldehyde-mediated copolymer system, we were able to demonstrate that for select tissue types, isoreactive titration of constituent polymer oxidation state and solid content impacts bioadhesion in a tissue-specific manner, and conversely do not impact generalized indicators of material biocompatibility. These findings imply that for a given clinical application (targeted tissue type), isoreactive tuning of a surgical sealant can be optimized such that adhesion is maximized while material biocompatibility remains at a baseline level that is determined by other factors (most notably the overall bioreactive group content of the material). Although only demonstrated in our experimental material system and with a limited number of soft tissue types, we expect that this design concept can be extended to a broad range of bioadhesive materials that target a specific surface-present chemical group for adhesive bond formation.
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